GFAT1 inhibitors form a chemical class of compounds specifically designed to selectively and reversibly target Glutamine Fructose-6-Phosphate Amidotransferase 1 (GFAT1), an enzyme that catalyzes the first and rate-limiting step in the hexosamine biosynthetic pathway. The hexosamine biosynthetic pathway plays a critical role in cellular metabolism and nutrient signaling. The inhibitors within this class are carefully engineered to interact with GFAT1, potentially modulating its enzymatic activity and disrupting the hexosamine biosynthetic pathway.
The chemical structure of GFAT1 inhibitors allows them to bind to specific regions or binding sites on the enzyme, interfering with its ability to convert fructose-6-phosphate and glutamine into glucosamine-6-phosphate. Researchers utilize GFAT1 inhibitors in biochemical and cellular studies to investigate the functions of GFAT1 in nutrient sensing and its implications in cellular metabolism. The design and development of these inhibitors are based on a comprehensive understanding of GFAT1's structural features and its involvement in hexosamine biosynthesis, providing essential tools for advancing research in the field of cellular metabolism and nutrient signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $306.00 $906.00 | 15 | |
Azaserine is a natural compound and an early-reported GFAT1 inhibitor, and it has been used in experimental studies to inhibit the hexosamine biosynthetic pathway. | ||||||
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $82.00 $285.00 $908.00 $2152.00 | ||
DON is a synthetic glutamine analog known to inhibit GFAT1 activity and disrupt the hexosamine biosynthetic pathway. | ||||||
Acivicin | 42228-92-2 | sc-200498B sc-200498C sc-200498 sc-200498D | 1 mg 5 mg 10 mg 25 mg | $102.00 $408.00 $642.00 $1275.00 | 10 | |
Acivicin is a glutamine analog that has been studied for its inhibitory effects on GFAT1 and the hexosamine biosynthetic pathway. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $197.00 $764.00 | ||
Glucosamine is a monosaccharide that serves as a substrate for GFAT1, and it has been used to competitively inhibit GFAT1 activity. | ||||||
C75 (racemic) | 191282-48-1 | sc-202511 sc-202511A sc-202511B | 1 mg 5 mg 10 mg | $71.00 $202.00 $284.00 | 9 | |
Originally developed as an inhibitor of fatty acid synthase, C75 has been reported to inhibit GFAT1 and disrupt hexosamine biosynthesis. | ||||||